BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25562820)

  • 1. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.
    The I; Ruijtenberg S; Bouchet BP; Cristobal A; Prinsen MB; van Mourik T; Koreth J; Xu H; Heck AJ; Akhmanova A; Cuppen E; Boxem M; Muñoz J; van den Heuvel S
    Nat Commun; 2015 Jan; 6():5906. PubMed ID: 25562820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans.
    Boxem M; van den Heuvel S
    Development; 2001 Nov; 128(21):4349-59. PubMed ID: 11684669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
    Paternot S; Colleoni B; Bisteau X; Roger PP
    Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
    Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
    Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
    Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
    Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
    Topacio BR; Zatulovskiy E; Cristea S; Xie S; Tambo CS; Rubin SM; Sage J; Kõivomägi M; Skotheim JM
    Mol Cell; 2019 May; 74(4):758-770.e4. PubMed ID: 30982746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Serrano M; Hannon GJ; Beach D
    Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex.
    Park M; Krause MW
    Development; 1999 Nov; 126(21):4849-60. PubMed ID: 10518501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D-CDK4/6 functions in cancer.
    Gao X; Leone GW; Wang H
    Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
    Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
    Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
    Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
    Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly.
    Braden WA; McClendon AK; Knudsen ES
    Oncogene; 2008 Nov; 27(56):7083-93. PubMed ID: 18776921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
    Wallace M; Ball KL
    Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.